Merck Sharp & Dohme LLC recalls Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme…
- Recall date
- December 12, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0241-2026
- FDA classification
- Class II
- Brand / firm
- Merck Sharp & Dohme LLC
- Sold / distributed
- Nationwide in the USA
Why it was recalled
Presence of particulate matter: potential presence of metal particulates in the product.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03
Get recall alerts
Free email alert whenever Merck Sharp & Dohme LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Merck Sharp & Dohme LLC